Jasper Therapeutics- Warrants (24/09/2026) Other Current Liabilities

As of the most recent data (June 2026), JSPRW shows a other current liabilities of $4.8M. That compares with $11M in the prior-year period — down 54.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JSPRW's other current liabilities is now $4.8M (was $11M) — a 54.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Jasper Therapeutics- Warrants (24/09/2026) is outperforming or lagging.

Tracking JSPRW's other current liabilities over time shows whether Jasper Therapeutics- Warrants (24/09/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $4.8M That compares with $11M in the prior-year period — down 54.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Jasper Therapeutics- Warrants (24/09/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $4.8M) with ownership activity and broader fundamentals.